Skip to main content
Erschienen in: Indian Journal of Pediatrics 2/2019

04.09.2018 | Original Article

Predicting Complicated Parapneumonic Effusion in Community Acquired Pneumonia: Hospital Based Case-Control Study

verfasst von: Meganathan P, Shally Awasthi

Erschienen in: Indian Journal of Pediatrics | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

To identify predictors of complicated parapneumonic effusion (CPE)/empyema in patients of community acquired pneumonia (CAP) by using clinical and simple laboratory variables like hemoglobin (Hb), serum C-reactive protein (CRP), serum albumin (SA) levels and total leukocyte counts (TLC).

Methods

This prospective case-control study was conducted after institutional ethical approval. Subjects between ages of 2–59 mo with World Health Organization (WHO) defined CAP with written, informed parental consent were included. Cases had CAP with CPE/empyema diagnosed by pleurocentesis. Controls had severe CAP without significant pleural collection on chest X-ray (CXR). Patients with congenital and chronic diseases/infections and possible immune deficiency were excluded. Variables with univariate association with case-control status were considered as potential predictors. Final prediction model was developed by Forward Stepwise Logistic Regression (FSLR). Adjusted odd’s ratios (Adj OR) were smoothened into nearest whole numbers to develop KGMU-CPE score.

Results

From 2016 to 17, 30 cases (66.6% males, age 38.7 + 14.9 mo) and 118 controls (78% males, age 17.8 + 16.9 mo) were included. In FSLR, predictors of CPE/empyema were ibuprofen intake (adj OR 6.8; 95%CI: 1.07–43.6), infective focus elsewhere (adj OR 28.2; 95%CI: 1.4–563.1), hypoalbuminemia <3.1 g/dL (adj OR 6.9; 95%CI: 1.22–39.3), serum CRP >20 mg/dL (adj OR 59; 95%CI: 1.86–1874.7), Hb <10 g/dL (adj OR 21.1; 95%CI: 2.8–158.1) and TLC >10,000 (adj OR 37; 95%CI: 5.7–239.8) and these six variables formed KGMU-CPE Score with a minimum score of 0 and maximum of 25. KGMU-CPE score area under the ROC curve was 0.97 and cut- off 15.55 had sensitivity of 80% and specificity of 94% for predicting CPE/empyema.

Conclusions

Using simple clinical and laboratory parameters it is possible to predict CAP with CPE/empyema. Use of ibuprofen is to be avoided in CAP as it associated with CPE. KGMU-CPE score had good diagnostic accuracy and needs external validation.
Literatur
2.
Zurück zum Zitat Krenke K, Krawiec M, Kraj G, Peradzynska J, Krauze A, Kulus M. Risk factors for local complications in children with community-acquired pneumonia. Clin Respir J. 2018;12:253–61.CrossRefPubMed Krenke K, Krawiec M, Kraj G, Peradzynska J, Krauze A, Kulus M. Risk factors for local complications in children with community-acquired pneumonia. Clin Respir J. 2018;12:253–61.CrossRefPubMed
3.
Zurück zum Zitat Maziah W, Choo KE, Ray JG, Ariffin WW. Empyema thoracis in hospitalized children in Kelantan, Malaysia. J Trop Pediatr. 1995;41:185–8. Maziah W, Choo KE, Ray JG, Ariffin WW. Empyema thoracis in hospitalized children in Kelantan, Malaysia. J Trop Pediatr. 1995;41:185–8.
4.
Zurück zum Zitat Mishra OP, Das BK, Jain AK, Lahiri TK, Sen PC, Bhargara V. Clinico-bacteriological study of empyema thoracis in children. J Trop Pediatr. 1993;39:380–1.CrossRefPubMed Mishra OP, Das BK, Jain AK, Lahiri TK, Sen PC, Bhargara V. Clinico-bacteriological study of empyema thoracis in children. J Trop Pediatr. 1993;39:380–1.CrossRefPubMed
5.
Zurück zum Zitat Deiros Bronte L, Baquero-Artigao F, García-Miguel MJ, Hernández González N, Peña García P, del Castillo Martín F. Parapneumonic pleural effusion: an 11-year review. An Pediatr (Barc). 2006;64:40–5.CrossRef Deiros Bronte L, Baquero-Artigao F, García-Miguel MJ, Hernández González N, Peña García P, del Castillo Martín F. Parapneumonic pleural effusion: an 11-year review. An Pediatr (Barc). 2006;64:40–5.CrossRef
6.
Zurück zum Zitat Anstadt MP, Guill CK, Ferguson ER, et al. Surgical versus nonsurgical treatment of empyema thoracis: an outcomes analysis. Am J Med Sci. 2003;326:9–14. Anstadt MP, Guill CK, Ferguson ER, et al. Surgical versus nonsurgical treatment of empyema thoracis: an outcomes analysis. Am J Med Sci. 2003;326:9–14.
7.
Zurück zum Zitat Dass R, Deka NM, Barman H, et al. Empyema thoracis: analysis of 150 cases from a tertiary care Centre in north East India. Indian J Pediatr. 2011;78:1371–7. Dass R, Deka NM, Barman H, et al. Empyema thoracis: analysis of 150 cases from a tertiary care Centre in north East India. Indian J Pediatr. 2011;78:1371–7.
8.
Zurück zum Zitat Strange C, Tomlinson JR, Wilson C, Harley R, Miller KS, Sahn SA. The histology of experimental pleural injury with tetracycline, empyema, and carrageenan. Exp Mol Pathol. 1989;51:205–19.CrossRefPubMed Strange C, Tomlinson JR, Wilson C, Harley R, Miller KS, Sahn SA. The histology of experimental pleural injury with tetracycline, empyema, and carrageenan. Exp Mol Pathol. 1989;51:205–19.CrossRefPubMed
9.
11.
13.
Zurück zum Zitat Prais D, Kuzmenko E, Amir J, Harel L. Association of hypoalbuminemia with the presence and size of pleural effusion in children with pneumonia. Pediatrics. 2008;121:e533–8.CrossRefPubMed Prais D, Kuzmenko E, Amir J, Harel L. Association of hypoalbuminemia with the presence and size of pleural effusion in children with pneumonia. Pediatrics. 2008;121:e533–8.CrossRefPubMed
14.
Zurück zum Zitat Niemi E, Korppi M. Parapneumonic empyema in children before the era of pneumococcal vaccination. Acta Paediatr. 2011;100:1230–3.CrossRefPubMed Niemi E, Korppi M. Parapneumonic empyema in children before the era of pneumococcal vaccination. Acta Paediatr. 2011;100:1230–3.CrossRefPubMed
16.
Zurück zum Zitat WHO Multicentre Growth Reference Study Group. WHO child growth standards: length/ height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization; 2006. WHO Multicentre Growth Reference Study Group. WHO child growth standards: length/ height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization; 2006.
17.
Zurück zum Zitat Prober CG, Srinivas NS, Mathew R. Central nervous system infections. In: Kleigman, Staton, St Geme, et al editors. Nelson Text book of Pediatrics, 20th ed. Philadelphia: Elsevier; 2016. p. 2936–46. Prober CG, Srinivas NS, Mathew R. Central nervous system infections. In: Kleigman, Staton, St Geme, et al editors. Nelson Text book of Pediatrics, 20th ed. Philadelphia: Elsevier; 2016. p. 2936–46.
19.
Zurück zum Zitat Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest. 2000;118:1158–71. Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest. 2000;118:1158–71.
20.
Zurück zum Zitat François P, Desrumaux A, Cans C, Pin I, Pavese P, Labarère J. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatr. 2010;99:861–6.CrossRefPubMed François P, Desrumaux A, Cans C, Pin I, Pavese P, Labarère J. Prevalence and risk factors of suppurative complications in children with pneumonia. Acta Paediatr. 2010;99:861–6.CrossRefPubMed
21.
Zurück zum Zitat Le Bourgeois M, Ferroni A, Leruez-Ville M, et al. Nonsteroidal anti-inflammatory drug without antibiotics for acute viral infection increases the empyema risk in children: a matched case-control study. J Pediatr. 2016;175:47–53.CrossRefPubMed Le Bourgeois M, Ferroni A, Leruez-Ville M, et al. Nonsteroidal anti-inflammatory drug without antibiotics for acute viral infection increases the empyema risk in children: a matched case-control study. J Pediatr. 2016;175:47–53.CrossRefPubMed
22.
Zurück zum Zitat Mazaleuskaya LL, Theken KN, Gong L, et al. PharmGKB summary: ibuprofen pathways. Pharmacogenet Genomics. 2015;25:96–106. Mazaleuskaya LL, Theken KN, Gong L, et al. PharmGKB summary: ibuprofen pathways. Pharmacogenet Genomics. 2015;25:96–106.
23.
Zurück zum Zitat Stevens DL. Could nonsteroidal anti-inflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis. 1995;21:977–80.CrossRefPubMed Stevens DL. Could nonsteroidal anti-inflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis. 1995;21:977–80.CrossRefPubMed
24.
Zurück zum Zitat Solberg CO. Influence of phenylbutazone on the phagocytic and bactericidal activities of neutrophil granulocytes. Acta Pathol Microbiol Scand B: Microbiol Immunol. 1974;82:258–62. Solberg CO. Influence of phenylbutazone on the phagocytic and bactericidal activities of neutrophil granulocytes. Acta Pathol Microbiol Scand B: Microbiol Immunol. 1974;82:258–62.
25.
Zurück zum Zitat Factor SH, Levine OS, Harrison LH, et al. Risk factors for pediatric invasive group a streptococcal disease. Emerg Infect Dis. 2005;11:1062–6. Factor SH, Levine OS, Harrison LH, et al. Risk factors for pediatric invasive group a streptococcal disease. Emerg Infect Dis. 2005;11:1062–6.
26.
Zurück zum Zitat Dilber E, Cakir M, Kalyoncu M, Okten A. C-reactive protein: a sensitive marker in the management of treatment response in parapneumonic empyema of children. Turkish J Pediatr. 2003;45:311–4. Dilber E, Cakir M, Kalyoncu M, Okten A. C-reactive protein: a sensitive marker in the management of treatment response in parapneumonic empyema of children. Turkish J Pediatr. 2003;45:311–4.
27.
Zurück zum Zitat Hsieh YC, Hsueh PR, Chun-Yi L, Lee PI, Lee CY, Huang LM. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis. 2004;38:830–5.CrossRefPubMed Hsieh YC, Hsueh PR, Chun-Yi L, Lee PI, Lee CY, Huang LM. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis. 2004;38:830–5.CrossRefPubMed
28.
Zurück zum Zitat Izhakian S, Wasser WG, Fox BD, Vainshelboim B, Kramer MR. The diagnostic value of the pleural fluid C-reactive protein in parapneumonic effusions. Dis Markers. 2016;2016:7539780.CrossRefPubMedPubMedCentral Izhakian S, Wasser WG, Fox BD, Vainshelboim B, Kramer MR. The diagnostic value of the pleural fluid C-reactive protein in parapneumonic effusions. Dis Markers. 2016;2016:7539780.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Wexler ID, Knoll S, Picard E, et al. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population. Pediatr Pulmonol. 2006;41:726–34. Wexler ID, Knoll S, Picard E, et al. Clinical characteristics and outcome of complicated pneumococcal pneumonia in a pediatric population. Pediatr Pulmonol. 2006;41:726–34.
30.
Zurück zum Zitat Kopec JA, Esdaile JM. Bias in case-control studies. A review. J Epidemiol Community Health. 1990;44:179–86. Kopec JA, Esdaile JM. Bias in case-control studies. A review. J Epidemiol Community Health. 1990;44:179–86.
31.
Zurück zum Zitat Laupacis A, Sekar M, Stiell IG. Clinical prediction rules: a review and suggested modifications of methodological standards. JAMA. 1997;277:488–94.CrossRefPubMed Laupacis A, Sekar M, Stiell IG. Clinical prediction rules: a review and suggested modifications of methodological standards. JAMA. 1997;277:488–94.CrossRefPubMed
32.
Zurück zum Zitat Childs JD, Cleland JA. Development and application of clinical prediction rules to improve decision-making in physical therapist practice. Phys Ther. 2006;86:122–31.CrossRefPubMed Childs JD, Cleland JA. Development and application of clinical prediction rules to improve decision-making in physical therapist practice. Phys Ther. 2006;86:122–31.CrossRefPubMed
Metadaten
Titel
Predicting Complicated Parapneumonic Effusion in Community Acquired Pneumonia: Hospital Based Case-Control Study
verfasst von
Meganathan P
Shally Awasthi
Publikationsdatum
04.09.2018
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 2/2019
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-018-2769-y

Weitere Artikel der Ausgabe 2/2019

Indian Journal of Pediatrics 2/2019 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.